To determine if MCHB fluorescence can permit non-invasive imaging of off-target activation of CNOB, we used similar breast tumor implants and supplied the (lac promoter-controlled)-chrR6 gene for CNOB activation using the above-mentioned ChrR6-generating bacteria injected via the tail vein. The gene discussed is LCT; the disease is breast neoplasm.